Geraghty et al. reported that bioactive A1AT could modulate phosphatase 2A, which played a key role in COPD and expressed on the neutrophils to prevent inflammatory and proteolytic responses triggered by TNF-α simulation in the lung [104]. The gene discussed is TNF; the disease is chronic obstructive pulmonary disease.